BioVie (BIVI)
(Delayed Data from NSDQ)
$2.76 USD
-0.07 (-2.47%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.75 -0.01 (-0.36%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 33% (84 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | NA | 0.88 | 61.00 |
Year Ago Quarter Estimate | -2.30 | 0.47 | 54.84 |
Next Quarter Estimate | NA | -1.06 | 63.00 |
Next Year Estimate | NA | 8.13 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 20.70 | 15.70 |
Next Year | NA | 16.30 | 11.30 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.82 |
Price/Book (MRQ) | 0.89 | 1.59 |
Price/Cash Flow (MRFY) | NA | 9.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -61.35% |
Return on Equity (TTM) | -294.42% | -58.93% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.